May 6, 2015 / 10:27 AM / 5 years ago

BRIEF-Plasmatech Biopharmaceuticals to acquire Abeona Therapeutics

May 6 (Reuters) - Plasmatech Biopharmaceuticals Inc -

* Plasmatech Biopharmaceuticals announces agreement to acquire Abeona Therapeutics LLC

* Says to issue to Abeona Therapeutic members total of 3.98 million shares upon closing of deal, and up to additional $9 million in performance milestones, in stock or cash

* Says the Abeona operating and scientific teams will remain intact; says Tim Miller, President & CEO of Abeona will succeed Scott Schorer, CEO of Plasmatech

* Says board of Plasmatech Biopharmaceuticals and managers of Abeona have unanimously approved the transaction Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below